Showing results (1361-1370 of 1,370) with videos related to

Sort By:
Pageof 137
You have reached the last page of results.This site can display upto 1,370 results.
The New England Journal of Medicine|November 16, 2011
Dronedarone in high-risk permanent atrial fibrillationStuart J Connolly, A John Camm, Jonathan L Halperin, et al.
Clinical Pharmacology and Therapeutics|June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systemsL J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Nature Communications|October 10, 2015
Genetic sharing and heritability of paediatric age of onset autoimmune diseasesYun R Li, Sihai D Zhao, Jin Li, et al.
Nature Medicine|August 25, 2015
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseasesYun R Li, Jin Li, Sihai D Zhao, et al.
Science (New York, N.Y.)|February 6, 2025
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variantsHongbo Liu, Amin Abedini, Eunji Ha, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Selection, optimization, and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
American Journal of Human Genetics|March 24, 2026
Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network studyLucinda P Lawson, Cynthia A Prows, Josh Cortopassi, et al.
Nature Medicine|February 20, 2024
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populationsNiall J Lennon, Leah C Kottyan, Christopher Kachulis, et al.
Lancet (London, England)|March 17, 2012
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis, Daniel I Swerdlow, Michael V Holmes, et al.
Pageof 137